Cancer News and Research

Latest Cancer News and Research

$First drug approved for hormone refractory prostate cancer that has shown a survival benefit$

First drug approved for hormone refractory prostate cancer that has shown a survival benefit

The the Food and Drug Administration (FDA) approved Taxotere (docetaxel), injection in combination with prednisone ( a steroid), for the treatment of patients with advanced metastatic prostate cancer. This is the first drug approved for hormone refractory prostate cancer that has shown a survival benefit.

19 May 2004

FDA approves new drug for bone marrow disease

The Food and Drug Administration (FDA) today announced the approval of Vidaza (azacitidine) injection, the first effective treatment for patients with Myelodysplastic Syndrome (MDS). The product was given Fast Track Status and a priority review.

19 May 2004

Drug combo effective for advanced breast cancer

A pair of studies at UCLA's Jonsson Cancer Center that takes laboratory science to the patients' bedside found that combining the molecularly targeted therapy Herceptin with a specific chemotherapy combination resulted in significant tumor response rates and longer relapse-free periods in women with an aggressive form of advanced breast cancer.

19 May 2004

National Cancer Institute (NCI) purchases Starbridge Hypercomputer® to accelerate genome data research

Starbridge Systems announced today that the National Cancer Institute's Advanced Biomedical Computing Center (ABCC) in Frederick, MD, recently purchased a Starbridge Hypercomputer®, the first high-end reconfigurable computer acquired for bioscience research.

19 May 2004

Centre for Life opens with the UK’s first two human embryonic stem cell lines

The UK’s first two human embryonic stem cell lines, developed separately by researchers at King’s College London and the Centre for Life in Newcastle, are to be deposited in the UK Stem Cell Bank. The deposit coincides with the official opening of the Bank by Health Minister, Lord Warner, today (Wednesday 19 May 2004).

19 May 2004

New generation of programmable chips set to revolutionise medical industry

The MI-3 project is focussing on developing and exploiting a new generation of programmable chips that will produce images that can be transformed even before they leave the camera. Active Pixel Sensors exploit the capabilities of Complimentary Metal Oxide Semi-Conductor (CMOS) Chips by allowing intelligent imaging that can focus right down to individual pixels.

19 May 2004

Inactivating a protective molecule may help chemotherapy for leukemia but harm bone marrow

Inactivating a protective molecule in leukemic cells to make them more vulnerable to chemotherapy might also make healthy blood-forming cells more sensitive to the toxic effects of those same drugs.

19 May 2004

Clinical trial of traditional Chinese medicine for the treatment of male infertility

Traditional Chinese Medicine (TCM) researcher Jann Mehmet knows the effectiveness of acupuncture and Chinese herbal medicine in treating male infertility. Now she is putting her observations to the test in a formal clinical trial of the benefits of TCM, the first time such a study has been conducted in Australia - or overseas.

18 May 2004

Benitec acquires Avocel to focus on rapid development of hepatitis C therapeutics

Benitec Ltd. today announced the acquisition of Avocel, Inc. of Sunnyvale, CA, a leading RNAi therapeutics company, and the establishment of its wholly-owned US subsidiary, Benitec, Inc. Through the acquisition, Benitec gains its first in-house advanced therapeutic development program using DNA-directed RNAi (ddRNAi) to target the Hepatitis C virus.

18 May 2004

Manipulation of the body’s own natural killer cells to destroy cells containing the HIV virus

Current treatments for HIV block the virus from replicating, but don’t kill the cells that contain HIV. The existence of these HIV-harboring cells -- often called the “latent” or “resting reservoir” -- is regarded by many to be the main obstacle to finding a cure for HIV.

18 May 2004

High levels of troponin I (TNI) protein in the blood helps identify possible heart damage after cancer treatment

TNI is a protein present exclusively in heart cells. The TNI blood concentration is a well-established marker of heart muscle injury that’s widely used to diagnose and treat heart attacks and other acute coronary syndromes.

18 May 2004

$1.4 million to investigate how strokes and other events that cut off blood flow to the brain disrupt the blood-brain barrier

The Cleveland Clinic has been awarded a four-year, $1.4 million grant from the National Institutes of Health to investigate how strokes and other events that cut off blood flow to the brain disrupt the blood-brain barrier. Researchers hope to use their findings to develop new methods to limit the damage caused by such events.

17 May 2004

British cancer charities call for improved lung cancer care

Today, MPs are being urged to support cancer charities' call for the provision of modern equipment vital to the treatment of people living with lung cancer, six months after the Government first promised to produce a national framework.

17 May 2004

New joint UK-Slovak health collaboration

A new joint UK-Slovak programme to boost collaboration into a range of medical conditions was announced by Health Minister John Huttontoday.Mr Hutton signed a joint agreement between the UK and Slovak Republic covering medicine and public health.

17 May 2004

New website for oral cancer prevention and detection

Every year in the United Kingdom, approximately 3, 500 people are diagnosed with oral cancer. About half these people will die of the disease. On average, four people in the UK die every day from oral cancer.

17 May 2004

One person per week dies in British hospitality industry from passive smoking

New figures to be presented at a Royal College of Physicians (RCP) conference today will show that every week in the UK one hospitality industry employee dies from passive smoking at work. The new figures, calculated by Professor Konrad Jamrozik of Imperial College in London, will be presented at the RCP conference called ‘Environmental Tobacco Smoke and the Hospitality Industry’.

17 May 2004

International plan to rid the world of dirty dozen most toxic chemicals known to humankind

The 2001 Stockholm Convention on Persistent Organic Pollutants (POPs) enters into force on Monday, May 17, marking the start of an ambitious international effort to rid the world of PCBs, dioxins and furans, and nine highly dangerous pesticides.

17 May 2004

Scientists have identified a compound that halts the activity of a deadly toxin called anthrax

University of Chicago scientists have identified a compound that halts the activity of a deadly toxin called anthrax lethal factor in laboratory tests. Nature Biotechnology will publish the findings online on May 16 and in the June issue of the journal's print edition.

17 May 2004

Inheriting the wrong version of a gene called CHEK2 doubles a woman's risk of developing breast cancer

Inheriting the wrong version of a gene called CHEK2 doubles a woman's risk of developing breast cancer, Cancer Research UK scientists confirm in a major new international study published in the June edition of the American Journal of Human Genetics.

17 May 2004

Researcher has learned how to maximize the cancer-fighting power of broccoli

University of Illinois researcher Elizabeth Jeffery has learned how to maximize the cancer-fighting power of broccoli. It involves heating broccoli just enough to eliminate a sulfur-grabbing protein, but not enough to stop the plant from releasing an important cancer-fighting compound called sulforaphane.

15 May 2004

Cancer News and Research

Latest Cancer News and Research

First drug approved for hormone refractory prostate cancer that has shown a survival benefit

FDA approves new drug for bone marrow disease

Drug combo effective for advanced breast cancer

National Cancer Institute (NCI) purchases Starbridge Hypercomputer® to accelerate genome data research

Centre for Life opens with the UK’s first two human embryonic stem cell lines

New generation of programmable chips set to revolutionise medical industry

Inactivating a protective molecule may help chemotherapy for leukemia but harm bone marrow

Clinical trial of traditional Chinese medicine for the treatment of male infertility

Benitec acquires Avocel to focus on rapid development of hepatitis C therapeutics

Manipulation of the body’s own natural killer cells to destroy cells containing the HIV virus

High levels of troponin I (TNI) protein in the blood helps identify possible heart damage after cancer treatment

$1.4 million to investigate how strokes and other events that cut off blood flow to the brain disrupt the blood-brain barrier

British cancer charities call for improved lung cancer care

New joint UK-Slovak health collaboration

New website for oral cancer prevention and detection

One person per week dies in British hospitality industry from passive smoking

International plan to rid the world of dirty dozen most toxic chemicals known to humankind

Scientists have identified a compound that halts the activity of a deadly toxin called anthrax

Inheriting the wrong version of a gene called CHEK2 doubles a woman's risk of developing breast cancer

Researcher has learned how to maximize the cancer-fighting power of broccoli

Cancer Research eBook

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Cancer News and Research

Latest Cancer News and Research

Cancer Research eBook

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Newsletters you may be interested in